Immucell (ICCC) Liabilities and Shareholders Equity (2009 - 2026)
Immucell (ICCC) recorded Liabilities and Shareholders Equity of $47.96 million in Q3 2026, up 12.8% from $42.53 million a year earlier and up 2.8% from the prior quarter.
Immucell (ICCC) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Immucell reported Liabilities and Shareholders Equity of $42.53 million, down 5.7% from FY2024.
- Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 1.1% (FY2020 to FY2025).
- Across earlier years, Liabilities and Shareholders Equity came in at $45.1 million in FY2024 (+3.0%), $43.81 million in FY2023 (-2.3%), $44.86 million in FY2022 (+0.9%) and $44.47 million in FY2021 (+10.2%).
- The Q3 2026 figure is the highest quarterly Liabilities and Shareholders Equity in data going back to Q1 2009.
- On a year-over-year basis, Liabilities and Shareholders Equity rose in five of the last eight quarters, with growth averaging 2.5%.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 17.9% in Q1 2022, against a decline of 7.7% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $46.63 million (Q2 2026), $44.11 million (Q1 2026) and $42.53 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 119.92 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Immucell | 102.43 Mn | 75.03 Mn | 3.56 Mn | 47.96 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 47.96 Mn |
| Jun 30, 2026 | 46.63 Mn |
| Mar 31, 2026 | 44.11 Mn |
| Dec 31, 2025 | 42.53 Mn |
| Sep 30, 2025 | 45.73 Mn |
| Jun 30, 2025 | 42.53 Mn |
| Mar 31, 2025 | 45.62 Mn |
| Dec 31, 2024 | 45.10 Mn |
| Sep 30, 2024 | 44.45 Mn |
| Jun 30, 2024 | 41.86 Mn |
| Mar 31, 2024 | 43.05 Mn |
| Dec 31, 2023 | 43.81 Mn |
| Sep 30, 2023 | 44.55 Mn |
| Jun 30, 2023 | 44.01 Mn |
| Mar 31, 2023 | 43.12 Mn |
| Dec 31, 2022 | 44.86 Mn |
| Sep 30, 2022 | 46.40 Mn |
| Jun 30, 2022 | 45.98 Mn |
| Mar 31, 2022 | 46.70 Mn |
| Dec 31, 2021 | 44.47 Mn |
Immucell Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();